HOME › DRUGS › DECITABINE
ACTIVE SUBSTANCE / INN

DECITABINE

Brand name(s): DACOGEN, Dacogen, DECITABINE, INQOVI
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA205582
NDA212576
ACTIVE SUBSTANCE
Decitabine
REGULATORS
FDA · EMA
SPONSORS / MAH
OTSUKA, ACCORD HLTHCARE, TAIHO ONCOLOGY
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DECITABINENDA205582SUN PHARMDiscontinued
DECITABINEANDA203475ACCORD HLTHCAREPrescription
INQOVINDA212576TAIHO ONCOLOGYPrescription
DACOGENNDA021790OTSUKADiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DacogenJanssen-Cilag International N.V.  Authorised20/09/2012Leukemia, Myeloid

FULL INTELLIGENCE ON DECITABINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →